MLS Laser Therapy for Joint and Spinal Pain Relief

Abstract

In this educational post, I walk you through how I set up and deliver modern multiwave locked system (MLS) laser therapy for low back pain, joint pain, and trigger points, emphasizing patient comfort, precise dosing, and seamless integration with chiropractic, rehabilitative exercise, and orthobiologic procedures such as PRP. I explain why we target energy density (J/cm²) rather than total joules, how robotic delivery and handheld emitters complement one another, and how we scale treatment fields with X–Y coordinates while the system auto-adjusts time to maintain dose.

I detail the physiology of photobiomodulation—how dual-wavelength light modulates nociception, microcirculation, mitochondrial function, and inflammatory signaling—so you can understand the immediate and cumulative benefits across acute and chronic conditions. I also share my clinical observations on fracture support (off-label), osteoarthritis knee dosing strategy, peri-PRP protocols, and how to optimize mitochondrial health with lifestyle and nutraceuticals. Throughout, I highlight how an integrative chiropractic model enhances outcomes by improving biomechanics, connective tissue mobility, and neuromuscular control while laser accelerates tissue recovery.

Patient-Centered Setup: Comfort, Precision, And Safety

As a clinician, my first priority in laser sessions is patient comfort. With robotic laser delivery, comfort and stability are critical—if the patient shifts, the precision of the dose and the targeting of the tissue field are compromised. For lumbar work, I position the patient prone and ensure the emitter has a direct line of sight to the skin. For handheld applications, certain tips must be placed directly on the skin; for robotic heads, we work at a set focal distance.

Key steps I follow:

• Ensure the treatment area is exposed and relaxed, with supports under the ankles or pelvis to reduce lumbar lordosis when needed.
• Confirm the skin-contact requirements for the handheld applicator versus the proper focal distance for the robotic head. The automated system provides a ruler-calibrated standoff—typically around six inches—to maintain beam collimation.
• Align to the symptomatic segment. For example, with suspected facet-mediated pain at L4–L5, I palpate, confirm side-dominance, and center my field over the likely pain generator and adjacent connective tissue.

Why this matters:

• Stable positioning reduces micro-movements that can shift the beam off target.
• Proper focal distance maintains the intended energy density at depth.
• Direct skin contact with the handheld allows precise delivery to small targets, such as trigger points or joint lines, while maintaining safety and consistent coupling.

Clinical pearl: I reassure patients they may feel nothing or, at most, gentle warmth or tingling. With MLS pulse timing in the nanosecond-to-microsecond domain, tissue heating is minimized while therapeutic photonic energy is absorbed efficiently (Anders et al., 2023).

Robotic And Handheld Emitters: A Complementary Strategy

In my practice, I frequently combine a robotic MLS emitter with a handheld diode applicator. Each tool has strengths:

• Robotic head
  • Best for covering a mapped region with a consistent dose (e.g., the lumbar paraspinals, including the facet regions).
  • Delivers multi-diode output at a fixed focal distance for uniform energy density.
  • Software allows me to set X and Y field size; time automatically recalibrates to maintain the target J/cm² as the area changes.
• Handheld emitter
  • Best for focal targets such as myofascial trigger points, joint spaces, and tight fascial bands.
  • Allows dynamic treatment while I perform gentle movement, muscle energy techniques, or fascial glides.
  • Single-diode precision at the skin surface for punctual dosing.

Why I combine them:

• The robot handles the global field—primary site plus regional connective tissue—to influence nociception, microcirculation, and fascial continuity.
• The handheld then “finishes” focal generators, such as taut bands or facet capsules, to improve local tissue texture and neurodynamics.

This aligns with what I call a clinical multimodal approach: not treating just the pain point but the source, the surrounding connective tissue network, and the neuromuscular system that stabilizes the region.

Dose Matters: Why We Target Energy Density (J/cm²), Not Just Joules

A central dosing concept in photobiomodulation is energy density—measured in joules per square centimeter (J/cm²). Instead of chasing large total joules, I target a therapeutic window per unit area, typically about 4–10 J/cm² for musculoskeletal indications, adjusting within that range based on the tissue depth and acuity (Bjordal et al., 2006; Chow et al., 2009; WALT, 2023).

• Target window: 4–10 J/cm² for many musculoskeletal conditions.
• Example: For lumbar facet pain with adjacent myofascial involvement, I often choose around 6 J/cm² across the defined field.
• The robotic system recalculates time as I adjust X–Y dimensions to maintain the same J/cm². This is crucial: enlarging the field without changing time would underdose the periphery; shrinking it could overdose the tissue.

Physiological rationale:

• Photobiomodulation exhibits a biphasic dose response (Arndt–Schulz law). Too little energy yields no effect; too much can attenuate or inhibit the response (Huang et al., 2011). Maintaining energy density within a validated therapeutic window optimizes mitochondrial activation and signaling without thermal overload or bioinhibition.

Practical application:

• If I need to deliver more overall energy to a complex joint (e.g., knee osteoarthritis), I do not increase J/cm² beyond the window at a single site. Instead, I dose multiple compartments—anteromedial, anterolateral, posterior horns—with the correct energy density at each field.

Understanding MLS Laser Technology: Wavelengths, Pulsing, And Thermal Safety

MLS therapy uses two wavelengths—typically 808 nm (continuous or modulated) and 905 nm (superpulsed). This combination is designed to:

• Enhance penetration depth: Near-infrared light (800–900 nm) penetrates relatively deeply into soft tissue.
• Balance power and safety: Superpulsed high-peak-power (e.g., up to 50 W in brief pulses) delivers energy without sustained heating because the low duty cycle and off-times allow thermal relaxation (Hashmi et al., 2010; Hamblin, 2017).
• Synchronize photochemical effects: While 808 nm supports mitochondrial chromophore absorption (cytochrome c oxidase), 905 nm superpulsing augments deeper reach and neurogenic modulation, potentially affecting C-fiber and A-delta signaling and microvascular tone (Chow et al., 2011; Anders et al., 2023).

What patients feel:

• Most feel nothing; some report faint warmth or tingling. If surface heat accumulates, I reassess the field, adjust parameters, or check coupling and motion. With proper MLS settings, tissue temperature generally remains stable during therapeutic dose delivery.

The Physiology Of Relief: From Acute Analgesia To Chronic Tissue Remodeling

To connect immediate and long-term effects, consider four interrelated mechanisms:

1. Nociceptive modulation

• Superpulsed near-infrared light can decrease conduction velocity in small-diameter pain fibers, modulate TRPV channels, and influence endogenous opioid and nitric oxide pathways, leading to rapid analgesia (Chow et al., 2011; Hamblin, 2017).
• Clinically, patients often report improved comfort within hours—commonly noticeable around 4–6 hours post-session. I ask patients to test their usual pain-provoking activities later the same day—for instance, on 2026-05-02 at around 17:00 if we treated at 11:00—to gauge functional change.

2. Microcirculation and edema control

• Photobiomodulation enhances endothelial nitric oxide and microvascular perfusion while stabilizing lymphatic flow, reducing local edema, and improving nutrient exchange (Huang et al., 2011).
• This improves the “tissue milieu” for healing, especially around facets, paraspinals, and periarticular structures.

3. Inflammatory and immune modulation

• PBM downshifts NF-?B activity, reduces proinflammatory cytokines (e.g., TNF-?, IL-1?), and can increase anti-inflammatory mediators (e.g., IL-10), steering the acute-to-resolving inflammatory transition (Anders et al., 2023).
• This is particularly valuable in chronic degenerative conditions, where maladaptive inflammation perpetuates pain and stiffness.

4. Mitochondrial activation and repair signaling

• At the mitochondrial level, photons absorbed by cytochrome c oxidase enhance electron transport, transiently increase reactive oxygen species within redox-signaling ranges, and elevate ATP production (Hamblin, 2017).
• The result is improved cellular energy, activation of transcription factors (e.g., Nrf2), and upregulation of antioxidant and repair genes—a basis for cumulative benefits over a 6–12-treatment series (Huang et al., 2011).

These mechanisms occur in overlapping timeframes; you cannot isolate the “anti-inflammatory” effect or the “mitochondrial” effect. However, parameter selection and session timing let us emphasize what the tissue needs at each stage.

Protocol Design: Acute, Chronic, And Peri-Orthobiologic Care

I tailor protocols to clinical goals and patient load:

• Acute conditions
  • Aim for 6 treatments as a focused series.
  • Frequency: ideally every 24 hours or three times per week (e.g., Monday–Wednesday–Friday).
  • Expect early analgesia in the first few sessions; reinforce completion of the full series to consolidate gains.
• Chronic conditions
  • 12 treatments are typical for chronic lumbar pain, spinal stenosis symptoms, or long-standing tendinopathy.
  • Maintain at least 24 hours between sessions; three per week works well.
  • Benefits are cumulative—stopping at session 3–5 risks relapse before mitochondrial and connective tissue remodeling consolidate.
• Peri-PRP/orthobiologics
  • Pre-injection “prime”: 2–3 sessions to improve microcirculation and calm nociceptive drive without suppressing the needed early inflammatory phase.
  • Day-of-injection: a session with parameters designed to support cellular viability and comfort without thermally stressing the tissue.
  • Post-injection: about 6 sessions to support remodeling, angiogenesis, and mitochondrial efficiency, dovetailing with rehab milestones.
  • Preliminary clinical reports and pilot data suggest additive benefits of PBM combined with PRP versus PRP alone in pain and function, consistent with PBM’s supportive biology (Anders et al., 2023; Hamblin, 2017).

Why I sequence this way:

• “Priming the soil” creates a well-perfused, lower-noise environment for biologics.
• Immediate post-procedure support can temper pain while preserving constructive inflammation.
• Subsequent sessions augment energy metabolism and tissue remodeling as the biologic graft matures.

Knee Osteoarthritis: Field Planning And Practical Dosing

For knee OA, dosing is not just a matter of pointing anteriorly at the patella. Most patellar surfaces reflect a majority of superficial light. I prefer:

• Slight knee flexion to open the joint space.
• Multi-compartment dosing: anteromedial, anterolateral, and posterior fields targeting the posterior horns of the menisci and capsular reflections.
• Maintain 4–10 J/cm² per field—often around 6–8 J/cm² based on body habitus and depth—rather than trying to accumulate more joules over one spot.

Rationale:

• Osteoarthritic pain drivers include synovitis, subchondral bone stress, capsular thickening, and myofascial dysfunction in the quadriceps and pes anserinus. A field strategy respects the three-dimensional pain architecture.
• In many patients, function improves faster when I combine joint-focused fields with myofascial trigger-point work in the quadriceps, hamstrings, and calves using the handheld emitter, along with joint-friendly exercise.

Trigger Points And The “Cooked vs. Raw” Tissue Heuristic

When palpating myofascial trigger points, I instruct trainees to feel for dense, tender “cooked” tissue within “raw,” pliable muscle. The handheld emitter excels at these particular targets:

• I deliver a brief, focused dose per trigger point—often around 25–45 seconds per spot with parameters tuned to achieve the target energy density.
• I integrate gentle contract-relax or active-assisted movement to lengthen the tissue while dosing.

Why this works:

• PBM reduces local nociception and improves microcirculation, thereby complementing manual techniques by facilitating sarcomere length normalization and decreasing central sensitization (Chow et al., 2011; Hamblin, 2017).

Avoiding Overdose: Respecting The Biphasic Dose Response

The Arndt–Schulz principle teaches that excessive doses can blunt benefits. In practice:

• Do not “pile on” energy in one spot, hoping for faster results.
• If more total energy is desired for a complex region, distribute correct J/cm² across multiple adjacent fields (e.g., lateral and medial aspects; anterior and posterior).
• Watch for surface warmth; if present, reassess technique and parameters.

This keeps tissue temperature stable over time while ensuring deep tissues receive effective photonic stimulation without bioinhibition (Huang et al., 2011).

Bone Healing Support: Off-Label, Clinically Observed

While not FDA-cleared in many markets for fracture healing, low-level and superpulsed lasers have been studied for osseous repair. Clinically, I have seen encouraging results when MLS therapy is initiated early—ideally within 7–10 days post-fracture—to support the inflammatory and soft callus phases. Practical notes:

• This is off-label and requires informed consent.
• Early, frequent dosing during the initial inflammatory window appears most helpful; nonunions are less responsive when initiated late.
• I target the periosteum and surrounding soft tissues with an appropriate J/cm² to promote perfusion and cellular activity (Posten & Wrone, 2005; Hamblin, 2017).

Always coordinate with orthopedics for fracture management and radiographic follow-up.

Integrative Chiropractic Care: How Manual Therapy And Exercise Enhance Laser Outcomes

MLS laser therapy is not a standalone solution. In my integrative model:

• Spinal and extremity adjustments restore joint play and neurosegmental input, decreasing aberrant nociception and improving motor control.
• Soft-tissue methods (myofascial release, instrument-assisted techniques, cupping) address fascial densification and trigger points that perpetuate pain.
• Corrective exercise reconditions the kinetic chain—hinge patterns, anti-rotation core work, hip abductors, and ankle mobility—to offload symptomatic segments.
• Ergonomics and sleep optimization further reduce inflammatory load and recurrent strain.

Why integration works:

• Laser increases tissue readiness—lower pain, better perfusion, and improved energy metabolism.
• Manual therapy and exercise convert that readiness into durable function by improving movement quality and loading tolerance (Bishop et al., 2016).
• Together, they address both the signal (pain/inflammation) and the system (biomechanics/behavior).

Safety, Durability, And Workflow

Device reliability and workflow considerations matter in busy clinics:

• Modern MLS systems are designed for long service life, with field service support when needed.
• Software auto-recalibrates treatment time as you change X–Y field size to maintain J/cm², preventing manual miscalculations.
• Treatments are efficient: regional robotic sessions often run 6–12 minutes; handheld trigger-point passes take seconds per spot.
• Reassure patients that relief may be noticeable within hours, and that benefits compound across sessions. Encourage them to test the function later the same day—for example, on 2026-05-02 at approximately 17:00—then report back.

Mitochondrial Optimization: Lifestyle And Nutraceutical Synergy

Given PBM’s mitochondrial mechanisms, many patients ask how to enhance these effects. My approach:

• Foundational habits
  • Sleep: 7–9 hours with consistent timing supports mitochondrial maintenance and glymphatic clearance.
  • Nutrition: emphasize polyphenols, omega-3s, adequate protein, and micronutrients (Mg, B-complex) to support electron transport and antioxidant defenses.
  • Movement: zone 2 aerobic work plus resistance training stimulates mitochondrial biogenesis through PGC-1? signaling.
• Evidence-aligned nutraceuticals
  • CoQ10 and ubiquinol can support electron transport, particularly in statin users, in whom CoQ10 depletion is well documented.
  • Creatine supports phosphate buffering for ATP-intensive tissues.
  • Alpha-lipoic acid, carnitine, and polyphenols (e.g., EGCG) may bolster redox balance and fatty acid shuttling.
  • NAD+ precursors (e.g., NR, NMN) remain under active investigation; clinical relevance varies by phenotype.
• Medication considerations
  • Some widely used drugs can impact mitochondrial function. While we never advise discontinuation without medical oversight, we can often mitigate effects with nutrition, timing, and targeted supplementation as appropriate.

The goal is not to “turn on” a single pathway but to create a cellular environment in which laser-delivered photonic energy translates into more efficient ATP generation, resilient redox signaling, and pro-repair gene expression (Hamblin, 2017; Anders et al., 2023).

Practical Case Flow: Low Back Pain With Facet Involvement

Here is how I translate this into a session:

• Assessment
  • History suggests facet-mediated pain at L4–L5 with right-sided referral.
  • Palpation reveals tenderness and localized myofascial tension.
  • Functional screens show painful extension and rotation.
• Setup
  • Patient prone, comfortable, skin accessible.
  • Robotic emitter aligned to center over the right L4–L5 region; X–Y field expanded to include adjacent paraspinals and thoracolumbar fascia.
  • Target energy density: approximately 6 J/cm² across this field.
• Delivery
  • Start an 8–10 minute robotic session.
  • While the robot runs, use the handheld applicator to treat discrete trigger points in the quadratus lumborum, gluteus medius, and piriformis—about 25–45 seconds per spot —to achieve the planned J/cm².
• Post-session guidance
  • Ask the patient to “test life” later the same day (e.g., 2026-05-02 at around 17:00): sit-to-stand transitions, light walking, or a gentle hinge pattern.
  • Reinforce completing the series—6 sessions for acute flare; 12 for chronic patterns—since effects are cumulative.
• Integrative plan
  • Layer in targeted spinal manipulation as indicated, hip hinge mechanics, anti-rotation core progressions, and breathing drills to reduce paraspinal overload.
  • Reassess weekly to adjust field size, J/cm² to keep it within the therapeutic window, and exercise progressions.

Frequently Asked Clinical Questions

• Do patients feel heat?
  • Usually not. With MLS, short pulses and rest periods allow thermal relaxation while delivering effective energy. If heat is noted, verify parameters, field distance, and coupling.
• Can lasers replace surgery?
  • Laser cannot reverse structural end-stage degeneration, such as advanced bone-on-bone arthritis. However, it can meaningfully reduce pain and inflammation, improve function, and in some cases delay or avoid surgery by supporting better biomechanics and symptom control (Chow et al., 2009).
• How do I manage dosing across multiple areas?
  • Keep J/cm² within the validated window for each field. If you need more comprehensive coverage, add fields rather than increasing the dose beyond the therapeutic range at one site.
• What about fracture care?
  • Off-label support may help if initiated within 7–10 days. Coordinate with orthopedics, secure informed consent, and dose periosteal and soft tissues appropriately.

Why Integrative Chiropractic Care Enhances Laser Outcomes

In my experience, the biggest clinical gains come when we:

• Use the robotic emitter to normalize the region’s physiology—nociception, perfusion, inflammation.
• Use the handheld to free focal barriers—trigger points, adhesions, capsular tightness.
• Apply precise chiropractic adjustments to restore segmental motion and neurosegmental balance.
• Build durable strength and mobility so the patient can take ownership of their improvements.

This is the difference between transient symptom relief and durable outcomes that change how a patient moves, sleeps, and lives.

Conclusion

MLS laser therapy provides a powerful, evidence-aligned tool for managing spine and joint pain when we respect dose, field geometry, and physiology. By prioritizing patient comfort, targeting energy density rather than raw joules, and combining robotic coverage with handheld precision, we influence both symptoms and the tissue environment. When integrated with chiropractic adjustments, soft-tissue care, and therapeutic exercise—and aligned with mitochondrial-supportive lifestyle changes—the result is a coherent, stepwise pathway from immediate relief to lasting function.

References

• Anders, J. J., Lanzafame, R. J., & Arany, P. R. (2023). Photobiomodulation: mechanisms and clinical applications. Photochemistry and Photobiology, 99(2), 331–349. https://doi.org/10.1111/php.13757
• Bjordal, J. M., Johnson, M. I., Iversen, V., Aimbire, F., & Lopes-Martins, R. A. B. (2006). Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects. Photomedicine and Laser Surgery, 24(2), 158–168. https://doi.org/10.1089/pho.2006.24.158
• Chow, R. T., Johnson, M. I., Lopes-Martins, R. A. B., & Bjordal, J. M. (2009). Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomized placebo or active-treatment controlled trials. The Lancet, 374(9705), 1897–1908. https://doi.org/10.1016/S0140-6736(09)61522-1
• Chow, R. T., Armati, P. J., Laakso, E.-L., Bjordal, J. M., & Baxter, G. D. (2011). Inhibitory effects of laser irradiation on peripheral mammalian nerves and relevance to analgesic effects: a systematic review. Photomedicine and Laser Surgery, 29(6), 365–381. https://doi.org/10.1089/pho.2010.2812
• Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. Journal of Biomedical Optics, 22(12), 121501. https://doi.org/10.1117/1.JBO.22.12.121501
• Hashmi, J. T., Huang, Y.-Y., Osmano?lu, Ü., Sharma, S. K., Naeser, M. A., & Hamblin, M. R. (2010). Low-level laser therapy: A meta-analysis of studies in depression and anxiety. Lasers in Surgery and Medicine, 42(6), 450–466. https://doi.org/10.1002/lsm.20965
• Huang, Y.-Y., Chen, A. C.-H., Carroll, J. D., & Hamblin, M. R. (2011). Biphasic dose response in low level light therapy. Dose-Response, 9(4), 602–618. https://doi.org/10.2203/dose-response.10-009.Hamblin
• World Association for Laser Therapy (WALT) dosage recommendations. Accessed 2026-05-02.